Schering-Plough Announces Transition of Animal Health Leadership
US – Schering-Plough Corporation has announced the transition of leadership of its Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who was previously the Deputy Head of the Animal Health unit.

Intervet / Schering-Plough Animal Health at IPVS 2008
SOUTH AFRICA - Durban, South Africa is the venue for the biggest bi-annual scientific congresses for swine practioners and scientists: the International Pig Veterinary Society Congress, held on June 23-26 2008.

Intervet/Schering-Plough Animal Health Appoints Heads of Global Swine
US – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment.

€11 billion deal seals Schering-Plough buyout
US - Schering-Plough Corporation has completed the acquisition of Organon BioSciences from Akzo Nobel. The deal has cost the company approximately Euro 11 billion in cash and creates the world's largest animal health organisation.

Third Quarter results confirm SPs solid position
NEW JERSEY - The finances of world-leading pharmaceutical giant Schering-Plough are very much in order. The company has recorded its 12th consecutive quarter of double-digit adjusted sales growth putting it in prime position for the integration of the...

Euro approval for the World's largest animal health business
EUROPE - Schering-Plough Corporation has received European Commission approval for its planned acquisition of Organon BioSciences, from Akzo Nobel.

Nuflor in-water: New option for respiratory disease control
UK - UK pig units with acute or chronic respiratory disease now have a powerful new tool at their disposal. Schering-Plough has built on the success of their injectable antibiotic, NUFLOR Swine by launching NUFLOR Drinking Water Concentrate (NUFLOR DWC)....

FDA Approves Broad-Spectrum Nuflor® Premix for Swine
US - Schering-Plough Animal Health Corporation has introduced another tool for helping the U.S. pork industry fight costly swine respiratory disease - without resorting to labor-intensive injections.

Schering-Plough To Acquire Intervet
NETHERLANDS - American based company Schering Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.

Global Animal Management Named First Interim Animal Tracking Database Provider for NAIS
US - Global Animal Management, Inc., a wholly-owned subsidiary of Schering-Plough Animal Health, announced today the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service has named the company as an interim animal tracking...

Vets should be the primary unit advisers, believes Ross Kelly
UK - Modern pig units comprise several single but importantly linked activities and the relationships with service and product suppliers, such as genetics and feed, are key in helping managers to get the best from their units and animals, says Ross Kelly,...

USDA Licenses Rhusigen® Erysipelas Vaccine
US - Schering Plough Animal Health Corporation now offers another important tool to help protect the health of pigs.

Growing And Finishing Pigs Set To Benefit As New Generation Antibiotic Gains Enteric Licence
UK - UK Pig producers with enteric conditions such as ileitis and swine dysentery have a powerful new in-feed option from Schering-Plough Animal Health. Previously licensed for treating respiratory disease, Aivlosin an entirely new macrolide is a pre-mix...

Scourmune® Improves Compliance in Prevention of Scours with Bilingual English-Spanish Label
US - In response to customer feedback, SPAH has announced it will be discontinuing the Scourmune® 25 dose vaccine (NDC# 0061-056206).

Schering-Plough Animal Health Commemorates 50th Anniversary
GLOBAL - Schering-Plough Animal Health Corp. (SPAH), a global leader in advancing the health and welfare of animals, is celebrating its 50th anniversary today.

Antibiotic resistance in pneumonia bacteria
UK - There are already resistant bacteria to two of three of the latest generation of antibiotics marketed for treatment of pneumonia in cattle, according to a study by Schering Plough Animal Health.

Major New Advancement in the Control of Erysipelas and Mycoplasma Pneumonia introduced
US - Schering-Plough Animal Health Corporation (Schering-Plough) today introduced M+Rhusigen™, a new vaccine containing major advancements to help swine producers control the devastating impact of both Erysipelas and Mycoplasma Pneumonia.

Schering-Plough launches Aivlosin - A new generation antibiotic for the treatment of enzootic pneumonia in finishing pigs
UK - UK pig producers seeking to manage Enzootic Pneumonia (EP) in their finishing herds now have access to a powerful new in-feed antibiotic option from Schering-Plough Animal Health.

New in-feed antibiotic for pigs - Aivlosin
UK - Schering-Plough Animal Heath have recently announced the launch of an innovative new antibiotic for use in feed.

Focusing in on Planned Farrowing
UK - Ross Kelly BVMS, MRCVS from Schering-Plough Animal Health, looks at the benefits of planned farrowing, pointing out that sows, piglets and stockpersons all gain from the practice.

Jury awards Boehringer-Ingelheim $6.905 million plus interest
US - A New Jersey jury has today rendered a decision in Schering-Plough's animal vaccine infringement suit.

Computer-modeling tool to forecast ROI of health programs
US - Properly managed vaccines and antibiotics are essential for managing the toughest diseases of swine. But let's face it, sometimes the payback on specific products or programs can be difficult to measure.

Schering-Plough's VeriSource To Revolutionize Livestock Management
US - Informatica Corporation announced that Global Animal Management Inc., a subsidiary of Schering-Plough Corporation, is successfully powering its industry-leading animal lifecycle management solution, VeriSource, using Informatica's enterprise...

SIV Gets More Complicated - Diagnosis and Treatment Include Larger Number of Virus Strains
US - Swine influenza virus (SIV) used to be a seasonal problem - pigs got sick in the fall and winter and then they got over it. Today's mix of SIV strains has turned swine flu into a year-round problem for swine producers.

Schering-Plough launches first trivalent SIV vaccine
US - Schering-Plough Animal Health has launched Maxivac® Excell 3, the industry's first trivalent vaccine for the costly swine influenza virus (SIV).